In particular, osteopontin expression is induced by hypoxia and its prognostic role in solid tumors is partially explained by its interplay with other hypoxia-related molecules and angiogenic factors, at least in head and neck and prostate cancer [48,49]. This evidence concerns the gene SPP1 and prostate cancer.